These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26689301)

  • 61. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 62. [Computerization and the importance of information in health system, as in health care resources registry].
    Troselj M; Fanton D
    Acta Med Croatica; 2005; 59(3):251-7. PubMed ID: 16095200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The matchmaker.
    Kiser K
    Minn Med; 2011 May; 94(5):12-5. PubMed ID: 21707002
    [No Abstract]   [Full Text] [Related]  

  • 64. Prevalence of leucocyte antibodies in the Dutch donor population.
    Middelburg RA; Porcelijn L; Lardy N; Briët E; Vrielink H
    Vox Sang; 2011 Apr; 100(3):327-35. PubMed ID: 20946548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors.
    Johansen KA; Schneider JF; McCaffree MA; Woods GL;
    Transfus Med; 2008 Aug; 18(4):250-9. PubMed ID: 18783584
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IRODaT: the International Online Registry for Organ Donation and Transplantation 2007.
    Mañalich R; Paez G; Valero R; Manyalich M
    Transplant Proc; 2009; 41(6):2030-4. PubMed ID: 19715825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How Can We Improve Retention of the First-Time Donor? A Systematic Review of the Current Evidence.
    Bagot KL; Murray AL; Masser BM
    Transfus Med Rev; 2016 Apr; 30(2):81-91. PubMed ID: 26971186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Organisation of blood transfusion services.
    Hewitt PE; Regan FA
    Br J Hosp Med; 1995 Oct 18-31; 54(8):383-6. PubMed ID: 8535589
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.
    Hurley CK; Foeken L; Horowitz M; Lindberg B; McGregor M; Sacchi N;
    Bone Marrow Transplant; 2010 May; 45(5):819-24. PubMed ID: 20173794
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Workshop on the clinical significance of red blood cell alloantibodies organized by the Working Party on Immunohaematology of the International Society of Blood Transfusion.
    Peyrard T
    Immunohematology; 2019 Sep; 35(3):105-107. PubMed ID: 31621369
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Laboratory costs of a hospital-based blood transfusion service in Malawi.
    Lara AM; Kandulu J; Chisuwo L; Kashoti A; Mundy C; Bates I
    J Clin Pathol; 2007 Oct; 60(10):1117-20. PubMed ID: 17412875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow….
    Bachelet T; Visentin J; Guidicelli G; Merville P; Couzi L; Taupin JL
    Transpl Int; 2016 Apr; 29(4):508-10. PubMed ID: 26762165
    [No Abstract]   [Full Text] [Related]  

  • 73. Prospects for the provision of genotyped blood for transfusion.
    Denomme GA
    Br J Haematol; 2013 Oct; 163(1):3-9. PubMed ID: 23889672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility.
    Edgren G; Rostgaard K; Vasan SK; Wikman A; Norda R; Pedersen OB; Erikstrup C; Nielsen KR; Titlestad K; Ullum H; Melbye M; Nyrén O; Hjalgrim H
    Transfusion; 2015 Jul; 55(7):1600-6. PubMed ID: 25573303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cameroon: official lethargy blamed for donor pull-out.
    AIDS Anal Afr; 1995 Jun; 5(3):9-10. PubMed ID: 12289044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stepwise access to safe plasma proteins in resource-constrained countries: Local production and pathways to fractionation-Report of an International Society of Blood Transfusion Workshop.
    Burnouf T; Epstein J; Faber JC; Smid M
    Vox Sang; 2022 Jun; 117(6):789-795. PubMed ID: 35262936
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modeling rare blood in Canada.
    Blake JT; Clarke G
    Transfusion; 2019 Feb; 59(2):582-592. PubMed ID: 30451305
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Problems in the development and use of an automated donor register for resolving the tasks of managing donor resources at a blood transfusion station].
    Sushchenko IB; Iniakina TI; Kalinina LA
    Gematol Transfuziol; 1988 May; 33(5):44-7. PubMed ID: 3410267
    [No Abstract]   [Full Text] [Related]  

  • 79. BLOOD DONOR PROBLEMS.
    HANTCHEF ZS; HOLLAENDER LP
    Bibl Haematol; 1964; 19():651-2. PubMed ID: 14267086
    [No Abstract]   [Full Text] [Related]  

  • 80. Standardization of cellular therapy terminology, coding and labeling: a review.
    Ashford P; Allman S; Larsson S; Loper K; Moniz K; Sims-Poston L; Slaper-Cortenbach I; Szczepiorkowski ZM
    Cytotherapy; 2022 Jun; 24(6):577-582. PubMed ID: 35370094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.